 TORRANCE, Calif., Dec. 9, 2021 PRNewswire -- Emmaus Life Sciences, Inc. OTCQX: EMMA, a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced that Yutaka Niihara, M.D. 